Use of cholinesterase antagonists to treat insulin resistance

Details for Australian Patent Application No. 2003201578 (hide)

Owner DiaMedica Inc.

Inventors Lautt, Wayne W

Agent Madderns

Pub. Number AU-B-2003201578

PCT Number PCT/CA03/00078

PCT Pub. Number WO2003/061648

Priority 60/350,958 25.01.02 US

Filing date 27 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 6 March 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/27 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/350,958 25.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003201578

9 December 2004 Amendment Made

  The nature of the amendment is: Delete the co-applicant Wayne W. Lautt.

6 March 2008 Application Accepted

  Published as AU-B-2003201578

3 July 2008 Standard Patent Sealed

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003201579-Use of glutathione synthesis stimulating compounds in reducing insulin resistance

2003201577-Use of phosphodiesterase antagonists to treat insulin resistance